Evidence map›Paper›PMID 22162554›Full record

ArticleJournal of clinical microbiology2012

Pneumonia and bacteremia due to Kytococcus schroeteri.

Ola Blennow, Katarina Westling, Inga Fröding, Volkan Ozenci

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Article
  2. Microorganisms · 2025
    Review
  3. Article
  4. Insight intoInfectious disease reports · 2021
    Article
  5. Article
  6. Postoperative Hardware-Related Infection fromCase reports in infectious diseases · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ola BlennowDepartment of Medicine, Division of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden. ola.blennow@karolinska.se
Katarina Westling
Inga Fröding
Volkan Ozenci
Office of Infectious Diseases · USKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kytococcus schroeteri, a saprophyte of the human skin, may cause serious infections in the immunocompromised host. Here, we describe a case of pneumonia and bacteremia due to Kytococcus schroeteri in an immunocompromised patient, successfully treated with linezolid and trimethoprim-sulfamethoxazole.

Indexed as

AcetamidesActinomycetalesActinomycetales InfectionsAdultAnti-Bacterial AgentsBacteremiaFemaleHumansImmunocompromised HostLinezolidOxazolidinonesPneumonia, BacterialTreatment OutcomeTrimethoprim, Sulfamethoxazole Drug CombinationAcetamidesAnti-Bacterial AgentsLinezolidOxazolidinonesTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID22162554
PMCPMC3264184
OpenAlexW1980850897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.